cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1993; 22:283-290
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Ferrari, G.
Right arrow Articles by Schwartz, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Ferrari, G.
Right arrow Articles by Schwartz, P.

Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction

GM De Ferrari, P Salvati, M Grossoni, G Ukmar, L Vaga, C Patrono, and PJ Schwartz

Istituto di Clinica Medica 2, Universita di Milano, Italy.

OBJECTIVES. The goal of the present study was to evaluate the antifibrillatory and hemodynamic effects of pharmacologic muscarinic activation and to compare them with those of beta-adrenergic blockade. BACKGROUND. Recent studies suggest a correlation between increased vagal activity and a reduced incidence of sudden cardiac death. Electrical stimulation of the vagus nerve reduces the incidence of ventricular fibrillation in a conscious animal model of sudden cardiac death. METHODS. Eleven dogs with healed anterior myocardial infarction, in which a 2-min left circumflex coronary artery occlusion during exercise caused ventricular fibrillation, were studied. They underwent subsequent tests with saline solution, propranolol (1 mg/kg body weight), methacholine (0.5 microgram/kg per min) and oxotremorine (8 micrograms/kg). RESULTS. In the test with saline solution, 100% of the dogs developed ventricular fibrillation; this occurred in only 10% of the tests with propranolol (95% confidence interval 0.2% to 44%; p < 0.001), 60% of the tests with methacholine (95% confidence interval 26% to 88%, p = 0.05) and 37.5% of the tests with oxotremorine (95% confidence interval 8% to 75%, p = 0.005). Propranolol and oxotremorine significantly reduced heart rate compared with saline solution, whereas methacholine did not. Propranolol significantly reduced maximal first derivative of left ventricular pressure, (dP/dtmax), particularly during myocardial ischemia, compared with the other treatments (2,391 +/- 582 mm Hg/s [mean +/- 1 SD] with propranolol vs. 4,226 +/- 1,237, 4,922 +/- 584 and 4,358 +/- 1,109 mm Hg/s with saline solution, methacholine and oxotremorine, respectively, p < 0.005). CONCLUSIONS. Propranolol was extremely effective against ventricular fibrillation. Methacholine and oxotremorine provided a significant, although less marked, protection and caused much less impairment of contractility compared with propranolol. Muscarinic receptor activation may represent a new approach to prevention of sudden cardiac death, particularly when beta-blockers are contraindicated and negative inotropic effects are to be avoided.


This article has been cited by other articles:


Home page
Exp PhysiolHome page
C. L. del Rio, T. A. Dawson, B. D. Clymer, D. J. Paterson, and G. E. Billman
Effects of acute vagal nerve stimulation on the early passive electrical changes induced by myocardial ischaemia in dogs: heart rate-mediated attenuation
Exp Physiol, August 1, 2008; 93(8): 931 - 944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Bibevski and M. E. Dunlap
Prevention of diminished parasympathetic control of the heart in experimental heart failure
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. T. La Rovere, C. Bersano, M. Gnemmi, G. Specchia, and P. J. Schwartz
Exercise-Induced Increase in Baroreflex Sensitivity Predicts Improved Prognosis After Myocardial Infarction
Circulation, August 20, 2002; 106(8): 945 - 949.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Kovoor, K. Wickman, C. T. Maguire, W. Pu, J. Gehrmann, C. I. Berul, and D. E. Clapham
Evaluation of the role of IKACh in atrial fibrillation using a mouse knockout model
J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2136 - 2143.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Iellamo, J. M. Legramante, M. Massaro, G. Raimondi, and A. Galante
Effects of a Residential Exercise Training on Baroreflex Sensitivity and Heart Rate Variability in Patients With Coronary Artery Disease : A Randomized, Controlled Study
Circulation, November 21, 2000; 102(21): 2588 - 2592.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Bibevski and M. E. Dunlap
Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure
Circulation, June 8, 1999; 99(22): 2958 - 2963.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C.-W. Chiou and D. P. Zipes
Selective Vagal Denervation of the Atria Eliminates Heart Rate Variability and Baroreflex Sensitivity While Preserving Ventricular Innervation
Circulation, July 28, 1998; 98(4): 360 - 368.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. E. Billman, L. C. Castillo, J. Hensley, C. M. Hohl, and R. A. Altschuld
ß2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation : In Vivo and In Vitro Evidence for Enhanced Sensitivity to ß2-Adrenergic Stimulation in Animals Susceptible to Sudden Death
Circulation, September 16, 1997; 96(6): 1914 - 1922.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Mortara, G. Specchia, M. T. La Rovere, J. T. Bigger Jr, F. I. Marcus, J. A. Camm, S. H. Hohnloser, R. Nohara, and P. J. Schwartz
Patency of Infarct-Related Artery : Effect of Restoration of Anterograde Flow on Vagal Reflexes
Circulation, March 15, 1996; 93(6): 1114 - 1122.
[Abstract] [Full Text]


Home page
CirculationHome page
S. S. Hull Jr, E. Vanoli, P. B. Adamson, G. M. De Ferrari, R. D. Foreman, and P. J. Schwartz
Do Increases in Markers of Vagal Activity Imply Protection From Sudden Death? : The Case of Scopolamine
Circulation, May 15, 1995; 91(10): 2516 - 2519.
[Abstract] [Full Text]



 
  cardiology careers collections past issues search home